Salbutamol → HCID 86744191, 화합물

HRID 1710226

반응식

HRID 1710226 반응식
CC(NCC(O)C1C=CC(O)=C(CO)C=1)(C)C.C(C1C=CC=CC=1)(=O)C.Br[CH2:28][C:29]([O:31][C:32](=[O:40])[C:33]1[CH:38]=[CH:37][CH:36]=[CH:35][C:34]=1[OH:39])=[O:30].[CH3:41][C:42]([NH:45][CH2:46][C:47]1[CH:52]=[CH:51][CH:50]=[CH:49][CH:48]=1)([CH3:44])[CH3:43]>>[CH3:44][C:42]([N:45]([CH2:28][C:29]([O:31][C:32](=[O:40])[C:33]1[CH:38]=[CH:37][CH:36]=[CH:35][C:34]=1[OH:39])=[O:30])[CH2:46][C:47]1[CH:52]=[CH:51][CH:50]=[CH:49][CH:48]=1)([CH3:41])[CH3:43]

참가 물질

5

반응물 4

HCID 2083SalbutamolHCID 7410AcetophenoneHCID 76908N-(1,1-Dimethylethyl)benzenemethanamineHCID 21684415Bromoacetyl-2-hydroxybenzoate

생성물 1

HCID 86744191HCID 86744191, 화합물

실험 절차

Albuterol has been prepared, see Irish Patent Specification No. 31391, Aug. 9, 1972, starting from the appropriate acetophenone derivative methyl-5-(bromoacetyl-2-hydroxybenzoate, by condensation with N-(1,1-dimethylethyl)benzenemethanamine in the presence of base to form the ketonic ester, methyl-5[[(1,1-dimethylethyl)(phenylmethyl)-amino]acetyl-2-hydroxybenzoate. The ketonic ester is reduced with lithium aluminum hydride in tetrahydrofuran under nitrogen to yield α1-[[(1,1-dimethylethyl)-(phenylmethyl)amino]methyl]-4-hydroxy-1,3-benzenedimethanol which is subsequently debenzylated with hydrogen in the presence of palladium on carbon catalyst to produce albuterol.

출처 및 근거

ORD 기록
ord-a7ee21119a7b4553868bb6ad80262184
출처 데이터셋
uspto-grants-1990_08
특허 번호
US04952729

연결된 노트

불러오는 중…